Epstein Secrets

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

ic of Germany Lino Guzzella Professor ETH Zurich Switzerland Bonnie W. Gwin Managing Partner. Board Practice Heidrick & Struggles USA H.R.H. Haakon of Norway Crown Prince of Norway Felix Haas Chief Executive Officer and Head of amiando AG Germany Product Richard N. Haass President Counci

f Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charles W. Ergen Chairman, President and

ic of Germany Lino Guzzella Professor ETH Zurich Switzerland Bonnie W. Gwin Managing Partner. Board Practice Heidrick & Struggles USA H.R.H. Haakon of Norway Crown Prince of Norway Felix Haas Chief Executive Officer and Head of amiando AG Germany Product Richard N. Haass President Counci

eller & Co. World Vision International Banco BTG Pactual The Financial Times Barclays UNI Global Union University of Miami Xinhua News Agency Novartis AG Bunge Limited Germany France Saudi Arabia USA United Kingdom Switzerland USA USA United Arab Emirates Mexico Saudi Arabia Switzerland U

for Economic Co-operation and Development (OECD). Paris Francis Gurry Director-General, World Intellectual Property Organization (WIPO), Geneva Haakon of Norway Crown Prince of Norway Richard N. Haass President Council on Foreign Relations USA World Economic Forum Annual Meeting EFTA_R1_02105